Life-threatening toxic epidermal necrolysis during voriconazole therapy for invasive aspergillosis after chemotherapy [3]

Annals of Oncology

Volumn 17, Issue 7, 2006, Pages 1174-1175

  Curigliano, Giuseppe ^a   Formica, V ^a   De Pas, T ^a   Spitaleri, G ^a   Pietri, E ^a   Fazio, N ^a   de Braud, F ^a   Goldhirsch, A ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; EPIRUBICIN; FLUOROURACIL; IMIPENEM; IMMUNOGLOBULIN; PHENYTOIN; VORICONAZOLE;

ADULT; ASPERGILLOSIS; BLISTER; BLOOD CULTURE; BRAIN METASTASIS; BREAST CANCER; CASE REPORT; CONTINUOUS INFUSION; DRUG DOSE REGIMEN; DRUG ERUPTION; DRUG FATALITY; DRUG FEVER; DRUG WITHDRAWAL; ERYTHEMA; GASTROINTESTINAL DISEASE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LUNG METASTASIS; MALE; PHOTOPHOBIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SKIN BIOPSY; SKIN ULCER; TOXIC EPIDERMAL NECROLYSIS;

EID: 33745617711     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj126     Document Type: Letter

References (2)

1. Herbrecht R, Denning DW, Patterson TF et al. (for the Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group). Voriconazole versus Amphotericin B for primary therapy of invasive Aspergillosis. N Engl J Med 2002; 347: 408-415.
2. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282 (5388): 490-493.